Literature DB >> 15818475

Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reductase-mediated gene amplification.

Seung Chul Jun1, Min Soo Kim, Jong Youn Baik, Sun Ok Hwang, Gyun Min Lee.   

Abstract

To evaluate the efficacy of selection strategies for recombinant Chinese hamster ovary (rCHO) clones undergone with dihydrofolate reductase-mediated gene amplification, rCHO cell lines producing a chimeric antibody were established using two strategies, one based on individual clones and the other based on cell pools. In a selection based on individual clones, cell cloning by limiting dilution method was performed twice, once after a round of selection of parental cell clones and once after obtaining high-producer clones. Thirty parental clones selected from 300 parental clones were cultivated independently throughout the gene amplification procedure. Using this labor-intensive strategy, it took approximately 17 weeks to obtain high-producing clones such as CS11-8 and CS18-3 clones. A selection based on cell pools, in which cell cloning was performed once at the final selection stage, required less effort and time to amplify large numbers of individual parental clones within the pool. However, high-producing clones were lost during the amplification procedure. The antibody expression level of high-producing clones such as PS7-2 and PS7-32 chosen on the basis of cell pools was less than one third of that of CS11-8 and CS18-3 clones. Taken together, a selection strategy based on individual clones is favored for establishment of high-producing rCHO clones because it is more efficient to perform cell cloning at the initial selection stage of parental cell clones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818475     DOI: 10.1007/s00253-005-1972-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system.

Authors:  Yoshinori Kawabe; Hirokatsu Makitsubo; Yujiro Kameyama; Shuohao Huang; Akira Ito; Masamichi Kamihira
Journal:  Cytotechnology       Date:  2011-09-25       Impact factor: 2.058

2.  Development of transfection and high-producer screening protocols for the CHOK1SV cell system.

Authors:  M Celina de la Cruz Edmonds; Melanie Tellers; Christine Chan; Peter Salmon; David K Robinson; Julia Markusen
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 3.  Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones.

Authors:  Wenwen Yang; Junhe Zhang; Yunxi Xiao; Wenqing Li; Tianyun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-17

4.  Determination of intracellular antibody production, cell density, and viability of recombinant CHO-DG44 cells using the MACSQuant® Analyzer.

Authors:  Jörn Pluschke; Sandra Klausing; Annika Haseloff; Bernd Schröder; Tanno Hübel
Journal:  BMC Proc       Date:  2011-11-22

5.  How a replication origin and matrix attachment region accelerate gene amplification under replication stress in mammalian cells.

Authors:  Shun-suke Tanaka; Sho-hei Mitsuda; Noriaki Shimizu
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

6.  Toxin-antitoxin based transgene expression in mammalian cells.

Authors:  K Nehlsen; S Herrmann; J Zauers; H Hauser; D Wirth
Journal:  Nucleic Acids Res       Date:  2009-12-08       Impact factor: 16.971

7.  Efficient recombinant production in mammalian cells using a novel IR/MAR gene amplification method.

Authors:  Yoshio Araki; Tetsuro Hamafuji; Chiemi Noguchi; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Fusion of the Dhfr/Mtx and IR/MAR gene amplification methods produces a rapid and efficient method for stable recombinant protein production.

Authors:  Chiemi Noguchi; Yoshio Araki; Daisuke Miki; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

9.  Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line.

Authors:  E V Voronina; Y A Seregin; N A Litvinova; V I Shvets; R R Shukurov
Journal:  Springerplus       Date:  2016-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.